Article info

Original research
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

Authors

  1. Correspondence to Dr Joachim Burman, Department of Neuroscience, Uppsala University Faculty of Medicine, Uppsala, Sweden; joachim.burman{at}neuro.uu.se
View Full Text

Citation

Zhukovsky C, Sandgren S, Silfverberg T, et al
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study

Publication history

  • Received May 25, 2020
  • Revised September 2, 2020
  • Accepted September 6, 2020
  • First published October 26, 2020.
Online issue publication 
January 15, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.